Michael SmedleyCohBar IncCOB.U.VTOP PICKOct 17, 2017

2 eminent Israeli scientists on the West Coast did things with mitochondria-based therapeutics for the treatment of age-related diseases 30 years ago. This is new in the market.

Michael Smedley

Owned

Unlock Rating

$6.15

Stock price when the opinion was issued

Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Most Recent Experts

Stockchase Insights

5i Research

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Michael SmedleyCohBar IncCOB.U.VTOP PICKOct 17, 2017

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals